Compagnie Lombard Odier SCmA
Q2 2021 13F-HR Holdings
Net value change ($000)
+12,383
(0.3%)
New positions
81
Sold out positions
88
Turnover %
6.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CRM | 49,616 | 1464.5% |
| GOOGL | 47,098 | 14.9% |
| AMZN | 30,340 | 13.1% |
| V | 29,887 | 15.6% |
| MSFT | 28,728 | 14.8% |
| BLK | 26,553 | 2870.6% |
| SE | 23,512 | 71248.5% |
| NOW | 22,953 | 9851.1% |
| EL | 20,561 | 310.7% |
| ADBE | 18,910 | 19.9% |
Top Reduces (Value $000, Stocks/ETFs)
| NTLA | -22,428 | -97.9% |
| TNDM | -20,144 | -99.7% |
| EXAS | -18,951 | -97.8% |
| ALLO | -18,947 | -100.0% |
| TXG | -17,880 | -100.0% |
| NEO | -17,411 | -100.0% |
| NTRA | -16,579 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -16,028 | -100.0% |
| APLS | -15,985 | -96.6% |
| Tabula Rasa HealthCare, Inc. | -15,857 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
797
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|